- Home
- HLF vs CRMD Comparison
HLF vs CRMD Comparison
Compare HLF & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLF
- CRMD
- Stock Information
- Founded
- HLF 1980
- CRMD 2006
- Country
- HLF United States
- CRMD United States
- Employees
- HLF N/A
- CRMD N/A
- Industry
- HLF Other Pharmaceuticals
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- HLF Health Care
- CRMD Health Care
- Exchange
- HLF Nasdaq
- CRMD Nasdaq
- Market Cap
- HLF 854.5M
- CRMD 877.5M
- IPO Year
- HLF N/A
- CRMD 2010
- Fundamental
- Price
- HLF $10.18
- CRMD $11.28
- Analyst Decision
- HLF Strong Buy
- CRMD Strong Buy
- Analyst Count
- HLF 4
- CRMD 7
- Target Price
- HLF $11.50
- CRMD $17.33
- AVG Volume (30 Days)
- HLF 1.7M
- CRMD 2.2M
- Earning Date
- HLF 08-06-2025
- CRMD 08-13-2025
- Dividend Yield
- HLF N/A
- CRMD N/A
- EPS Growth
- HLF 100.43
- CRMD N/A
- EPS
- HLF 2.74
- CRMD 0.28
- Revenue
- HLF $4,950,500,000.00
- CRMD $82,553,827.00
- Revenue This Year
- HLF $0.10
- CRMD $238.38
- Revenue Next Year
- HLF $4.12
- CRMD $53.52
- P/E Ratio
- HLF $3.78
- CRMD $40.46
- Revenue Growth
- HLF N/A
- CRMD N/A
- 52 Week Low
- HLF $5.04
- CRMD $3.61
- 52 Week High
- HLF $12.79
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- HLF 70.07
- CRMD 39.54
- Support Level
- HLF $9.63
- CRMD $11.13
- Resistance Level
- HLF $10.56
- CRMD $11.86
- Average True Range (ATR)
- HLF 0.42
- CRMD 0.65
- MACD
- HLF 0.13
- CRMD -0.34
- Stochastic Oscillator
- HLF 87.03
- CRMD 3.81
About HLF Herbalife Ltd.
Herbalife Ltd is an international nutrition company that provides health and wellness products to consumers in 95 markets, which consist of countries and territories, through their direct-selling business model. Companies' products are weight management, targeted nutrition, Energy, Sports and Fitness, Outer Nutrition and Literature, Promotional, and Other. Weight management generates the majority of revenue from products like Meal replacements, protein shakes, drink mixes, weight loss enhancers, and healthy snacks. Geographically, the main segments are North America, Latin America, EMEA, Asia Pacific regions, and China.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.